MangoceuticalsMGRX
13F holders, Q1 2025 (March 31)8holders −1
1new positions
2sold out
$1.95avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Ackerman Capital Advisors, LLC ($67K), Geode Capital Management, LLC ($38K) and UBS Group AG ($15K).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6K |
| Exits | 2 | $82K |
All 13F filers, Q4 2024 → Q1 2025: 18,942 shares bought and 34,963 shares sold, net −16,021 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Ackerman Capital Advisors, LLC | 0.02% | No change | 34,500 | $67K |
| Geode Capital Management, LLC | 0.00% | Add +63.0% | 19,570 | $38K |
| UBS Group AG | 0.00% | Add +392.8% | 7,510 | $15K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +54.4% | 7,100 | $14K |
| Osaic Holdings, Inc. | 0.00% | New | 2,885 | $6K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2,094 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -37.6% | 1,643 | $3K |
| Bank of America Corp. | 0.00% | Add +36.4% | 15 | $29 |
"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.